Bcl-2 as a clinical prognostic marker. | Download Table
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy | Cell Death & Disease
Cancers | Free Full-Text | Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
The prognostic role of Bcl-2, Ki67, c-MYC and p53 in diffuse large B-cell lymphoma. | Semantic Scholar
Noncanonical Cell Fate Regulation by Bcl-2 Proteins: Trends in Cell Biology
Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: A retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | British Journal of Cancer
Bcl-2 as a clinical prognostic marker. | Download Table
Bcl-2 - Wikipedia
Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review)
IVD Antibody Development Services for BCL-2 Marker - Creative Biolabs
Targeting BCL2 for the Treatment of Lymphoid Malignancies - ScienceDirect
Ancient and conserved functional interplay between Bcl-2 family proteins in the mitochondrial pathway of apoptosis | Science Advances
Dysregulation of BCL-2 family proteins by leukemia fusion genes - Journal of Biological Chemistry
PDF) BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | ResearchGate
bcl-2 expression in head and neck cancer: an enigmatic prognostic marker - International Journal of Radiation Oncology, Biology, Physics
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2 | Scientific Reports
BCL-2 Pathophysiology & Role in Apoptosis | Genentech Oncology
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | British Journal of Cancer
PDF) BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received | ResearchGate
Frontiers | The Multifaceted Roles of the BCL-2 Family Member BOK
Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer | Scientific Reports
Targeting BCL2 for the Treatment of Lymphoid Malignancies - ScienceDirect
Targeting BCL-2 regulated apoptosis in cancer | Open Biology
Pathology Outlines - BCL2
